Atlas of Indium-111 Antimyosin Imaging of Myocardial Necrosis

  • Robert C. Hendel
Part of the Atlases of Clinical Nuclear Medicine book series (ATLASES)


Ischemic heart disease is the major cause of mortality in industrialized nations. In the United States, more than 1.5 million myocardial infarctions occur each year. Usually the diagnosis may be made using standard clinical, electrocardiographic, and enzyme analysis methods for the detection of cardiac injury. However, up to 30% of all acute myocardial infarctions may have an equivocal initial diagnosis. Other cardiac disorders also may lead to either focal or global myocardial injury, such as with myocarditis or cardiac contusion. Thus, methods for the detection of myocardial necrosis have important clinical applications for cardiovascular medicine. Additionally, the localization and assessment of the extent myocardial necrosis has prognostic utility.


Myocardial Necrosis Myocardial Uptake Blunt Chest Trauma Cardiac Myosin Myosin Filament 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Khaw BA, Scott J, Fallon JT, et al. Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres. Science. 1982; 217: 1050–1053.PubMedCrossRefGoogle Scholar
  2. 2.
    Khaw BA, Fallon JT, Beller GA, Haber E. Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Circulation. 1979; 60: 1527–1531.PubMedGoogle Scholar
  3. 3.
    Khaw BA, Beller GA, Haber E, Smith TW. Localization of cardiac myosin-specific antibody in myocardial infarction. JClin Invest. 1976; 58: 439–446.CrossRefGoogle Scholar
  4. 4.
    Johnson LL, Seldin DW, Becker LC, et al. Antimyosin imaging in acute trans-mural myocardial infarctions: results of a multicenter clinical trial. JAm Coll Cardiol. 1989; 13: 27–35.CrossRefGoogle Scholar
  5. 5.
    Khaw BA, Yasuda T, Gold HK, et al. Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab. JNucl Med. 1987; 28: 1671–1678.Google Scholar
  6. 6.
    Takeda K, LaFrance ND, Weisman HF, et al. Comparison of indium-111 anti-myosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction. JAm Coll Cardiol. 1991; 17: 519–26.CrossRefGoogle Scholar
  7. 7.
    Khaw BA, Gold HK, Yasuda T, et al. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. Circulation. 1986; 74: 501–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Volpini M, Giubbini R, Gei P, et al. Diagnosis of acute myocardial infarction by indium-111 antimyosin antibodies and correlation with the traditional techniques for the evaluation of extent and localization. Am J Cardiol. 1989; 63: 713.CrossRefGoogle Scholar
  9. 9.
    Jain D, Lahiri A, Crawley JCW, Raftery EB. Indium-111 antimyosin imaging in a patient with acute myocardial infarction: postmortem correlation between histopathologic and autoradiographic extent of myocardial necrosis. Am J Cardiac Imag. 1988; 2: 158–161.Google Scholar
  10. 10.
    Hendel RC, McSherry B, Leppo JA. Myocardial uptake of Indium-111–1abeled antimyosin in acute subendocardial infarction: clinical, histochemical, and autoradiographic correlation of myocardial necrosis. JNucl Med. 1990; 31: 1851–3.Google Scholar
  11. 11.
    Jain D, Crawley JC, Lahiri A, Raftery EB. Indium-111-antimyosin images compared with triphenyl tetrazolium chloride staining in a patient six days after myocardial infarction. JNucl Med. 1990; 31: 231–233.Google Scholar
  12. 12.
    Berger H, Lahiri A, Leppo J, et al. Antimyosin imaging in patients with ischemic chest pain: initial results of phase III multicenter trial. JNucl Med. 1988; 29: 805–806.Google Scholar
  13. 13.
    Antunes ML, Tresgallo ME, Seldin DW, et al. Effect of infarct size measured from antimyosin single photon emission computed tomography scans on left ventricular remodeling. JAm Coll Cardiol. 1991; 18: 1263–70.CrossRefGoogle Scholar
  14. 14.
    Yamada T, Tamaki N, Morishima S, et al. Time course of myocardial infarction evaluated by indium-111-antimyosin monoclonal antibody scintigraphy: clinical implications and prognostic value. JNucl Med. 1992; 33: 1501–1508.Google Scholar
  15. 15.
    Matsumori A, Yamada T, Tamaki N, et al. Persistent uptake of indium-111antimyosin monoclonal antibody in patients with myocardial infarction. Am Heart J. 1990; 120: 1026–1030.PubMedCrossRefGoogle Scholar
  16. 16.
    Tamaki N, Yamada T, Matsumori A, et al. Indium-111-antimyosin antibody imaging for detecting different stages of myocardial infarction: comparison with technetium-99m-pyrophosphate imaging. JNucl Med. 1990; 31: 136–142.Google Scholar
  17. 17.
    Johnson LL, Seldin DW, Keller AM, et al. Dual isotope thallium and indium antimyosin SPECT imaging to identify acute infarct patients at further ischemic risk. Circulation. 1990; 81: 37–45.PubMedCrossRefGoogle Scholar
  18. 18.
    Matsumori A, Ohkusa T, Matoba Y, et al. Myocardial uptake of antimyosin monoclonal antibody in a murine model of viral myocarditis. Circulation. 1989; 79: 400–405.PubMedCrossRefGoogle Scholar
  19. 19.
    Yamada T, Matsumori A, Watanabe Y, et al. Pharmacokinetics of indium111-labeled antimyosin monoclonal antibody in murine experimental viral myocarditis. JAm Coll Cardiol. 1990; 16: 1280–1286.CrossRefGoogle Scholar
  20. 20.
    Yasuda T, Palacios IF, Dec GW, et al. Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocardial myocarditis. Circulation. 1987; 76: 306–311.PubMedCrossRefGoogle Scholar
  21. 21.
    Dec GW, Palacios I, Yasuda T, et al. Antimyosin antibody cardiac imaging its role in the diagnosis of myocarditis. JAm Coll Cardiol. 1990; 16: 97–104.CrossRefGoogle Scholar
  22. 22.
    Carrió I, Bernd L, Ballester M, et al. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. JNucl Med. 1988; 29: 1893–1900.Google Scholar
  23. 23.
    Obrador D, Ballester M, Carrio, et al. High prevalence of myocardial monoclonal antimyosin antibody uptake in patients with chronic idiopathic dilated cardiomyopathy. JAm Coll Cardiol. 1989; 13: 1289–1293.CrossRefGoogle Scholar
  24. 24.
    Matsumori A, Yamada T, Tamaki N, et al. Prognostic significance of indium-111 antimyosin antibody uptake in patients with dilated and hypertrophic cardiomyopathy. Int JCardiol. 1991; 32: 75–82.CrossRefGoogle Scholar
  25. 25.
    Addonizio LJ, Michler RE, Marboe C, et al. Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab. JAm Coll Cardiol. 1987; 9: 555–564.CrossRefGoogle Scholar
  26. 26.
    Frist W, Yasuda T, Segall G, et al. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging. Circulation. 1987; 76 (Suppl V): 1–85.Google Scholar
  27. 27.
    Ballester-Rodés M, Carrió I, Abadal-Beríni L, et al. Patterns of evolution of myocyte damage after human heart transplantation detected by indium-111 monoclonal antimyosin. Am J Cardiol. 1988; 62: 623–627.PubMedCrossRefGoogle Scholar
  28. 28.
    Ballester M, Obrador D, Carrio I, et al. Early postoperative reduction of monoclonal antimyosin antibody uptake is associated with absent rejection-related complications after heart transplantation. Circulation. 1992; 85: 61–68.PubMedGoogle Scholar
  29. 29.
    Estorch M, Carrio I, Berna L, et al. Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer. J Nucl Med. 1990; 31: 1965–1969.PubMedGoogle Scholar
  30. 30.
    Hendel RC, Cohn S, Aurigemma G, et al. Focal myocardial injury following blunt chest trauma: a comparison of indium-111 antimyosin scintigraphy with other noninvasive methods. Am Heart J. 1992; 123: 1208–1215.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1994

Authors and Affiliations

  • Robert C. Hendel

There are no affiliations available

Personalised recommendations